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Purpose: To evaluate the individual and interactive effects of polymorphisms in the myocilin (MYOC), optineurin
(OPTN), WD repeat domain 36 (WDR36), and apolipoprotein E (APOE) genes on primary open-angle glaucoma (POAG)
in northern Chinese.
Methods: Northern Chinese study subjects, 176 POAG patients and 200 controls, were recruited for screening of the
coding exons and splicing regions of MYOC. Five single nucleotide polymorphisms (SNPs) in OPTN (M98K, R545Q,
IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A), one SNP in WDR36 (IVS5+30C>T) as well as the APOE promoter and
ε2/ε3/ε4 polymorphisms were also examined. Association analysis was performed by using χ2 analysis. High-order gene-
gene interaction was also analyzed using the multifactor dimensionality reduction (MDR) method.
Results: In MYOC, 22 variants were identified. Four of them were novel but found in controls only. The missense mutation,
Val53Ala, is likely a glaucoma causing mutation, accounting for 0.6% of cases. No individual polymorphism in OPTN,
WDR36, or APOE was associated with POAG. MDR analysis identified a best 6-factor model for POAG: MYOC
IVS2+35A>G,  OPTN  Met98Lys,  OPTN  IVS5+38T>G,  OPTN  IVS8–53T>C,  WDR36  IVS5+30C>T,  and  APOE
−491A>T.
Conclusions: The association pattern between the genes, MYOC, OPTN, WDR36, and APOE, and POAG in northern
Chinese is different from that of southern Chinese. Disease-causing mutations in MYOC accounted for a small proportion
of northern Chinese POAG patients. Common polymorphisms in these genes were not associated with POAG individually
but might interactively contribute to the disorder, supporting a polygenic etiology.
Glaucoma is a heterogeneous group of optic neuropathies
characterized by progressive degeneration of the optic nerve
that leads to irreversible loss of vision. It is the second leading
cause of blindness worldwide, estimated to affect about 70
million people [1]. Primary open-angle glaucoma (POAG,
OMIM 137760) is the major type of primary glaucoma in most
populations.  It  is  evidenced  as  a  complex  disorder  with
multiple  risk  factors,  and  genetic  factors  may  play  an
important role in the etiology of this disorder.
So far, at least 22 genetic loci had been linked to POAG
[2-4], and three genes have been identified for POAG from
the reported loci, myocilin (MYOC, OMIM 601652) [5,6],
optineurin (OPTN, OMIM 602432) [7,8], and WD repeat-
domain 36 (WDR36, OMIM 609669) [9]. However, mutations
in these three genes account for less than 10% of POAG cases.
Therefore, it had been assumed that only a portion of POAG
follows the classical Mendelian inheritance while others are
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caused by variants in several genes, each of which contributes
minor  effects  to  disease  onset  and  pathogenesis  [10-12].
Presumably,  many  different  genes,  each  with  allelic
variations, contribute to the observed variability in a trait, with
no particular gene having a single dominant effect [13]. It is
likely that single nucleotide polymorphisms (SNPs) in a single
gene contributes only a small effect to disease [14] while some
genetic variations do not cause diseases individually but act
through interaction with other genes. Recently, Park’s study
[15] had revealed that OPTN could regulate the expression of
MYOC  primarily  through  the  control  of  mRNA  stability,
indicating that interaction exists between the two glaucoma
genes. In addition, apolipoprotein E (APOE; OMIM 107741)
has also been reported to be a potent modifier gene and may
interactively  contribute  to  POAG  [10,11].  These  findings
provided  evidence  for  the  multigenic  characteristics  of
POAG.
To date, the reported findings on glaucoma genetics in
Chinese are mostly based on southern Chinese of Hong Kong
[2-4,11,16,17], while relevant genetic information from the
northern Chinese was limited. Recently, however, a genomic
analysis revealed that the genetic ancestries of Chinese can be
divided into a southern and a northern group [18]. Therefore,
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89in this present study, we evaluated the genetic association of
MYOC,  OPTN,  WDR36,  and  APOE  polymorphisms  with
POAG  in  a  group  of  northern  Chinese.  The  distribution
patterns  of  the  gene  variants  between  the  northern  and
southern  Han  populations  were  also  compared  to  discern
whether any differential distributions of gene variants exist.
Moreover,  possible  gene-gene  interactions  among  the
variants in these genes were also evaluated. Statistically, for
gene-gene interaction analysis, logistic regression (LR) is a
commonly used method in case-control studies. However, it
had been suggested that LR is less powerful if individual
variables did not have significant main effects. Only variables
that contain an independent main effect will be included in the
final model [19]. Moreover, LR is less suitable for a large
number of polymorphisms as more analyzed parameters may
lead to higher likelihood of false positive and false negative
results [20]. In contrast, multifactor dimensionality reduction
(MDR) is a nonparametric method, which is less problematic
in dimensionality, and is useful for analyzing the interactions
among a large number of polymorphisms [20-23]. Therefore,
LR was used to analyze the pairwise gene-gene interaction if
any two gene variants are found to have significant main
effects on POAG. Otherwise, MDR was applied to explore the
high-order gene-gene interaction that may be involved in the
genetic  architecture  of  POAG  in  the  northern  Chinese
population.
METHODS
Case and control study subjects: Unrelated POAG patients
and control subjects were recruited from the Eye Center of
Beijing Tongren Hospital (Beijing, China). All the subjects
are Han Chinese. They came from Beijing or nearby areas,
representing a northern Chinese group. Diagnosis of POAG
was based on exclusion of congenital glaucoma and secondary
causes  (trauma,  uveitis,  or  steroid-induced  glaucoma),
anterior chamber angle open (grade III or IV gonioscopy),
optic disc changes (vertical cup-to-disc ratio greater than 0.5,
disc hemorrhage, or thin or notched neuroretinal rim), and
visual field changes according to Anderson’s criteria [24].
Visual  acuity  was  determined  by  the  Snellen  eye  chart,
intraocular  pressure  (IOP)  by  applanation  tonometry,  and
visual field by a perimeter (Humphrey Field Analyzer; Carl
Zeiss Meditec, Dublin, CA) with the Glaucoma Hemifield
test. Unrelated control subjects were recruited from people
attending the Tongren Eye Center for conditions such as senile
cataract, floaters, and itchy eyes. They were given the same
ophthalmic examinations and were diagnosed not to have
glaucoma or other major eye diseases.
In our study, we included subjects with juvenile onset
open-angle glaucoma (JOAG) and adult onset POAG. Totally,
there were 176 sporadic patients with POAG, 138 males and
38 females, with age at diagnosis ranging from 10 to 82 years
(mean±SD: 38.92±16.33) and with the highest recorded IOP
before treatment being higher than 21 mmHg. We included
control subjects aged 60 or above as they are less likely to
develop POAG later in their lives. There were 200 control
subjects, 150 males and 50 females, with age ranging from 61
to 85 years (mean±SD: 69.41±5.97) and with the highest
recorded IOP of less than 18 mmHg. The study protocol was
approved by the Ethics Committee for Human Research of
Tongren Hospital and Capital Medical University (Beijing,
China)  and  adhered  to  the  tenets  of  the  Declaration  of
Helsinki.  Informed  consent  was  obtained  from  all  study
subjects  after  explanation  of  the  nature  and  possible
consequences of the study. Venous blood was obtained from
the subjects and stored at −20 °C for less than two months
before DNA extraction.
Analysis  of  the  MYOC  sequences  and  single  nucleotide
polymorphisms  in  OPTN,  WDR36,  and  APOE:  Genomic
DNA was extracted from 200 μl of whole blood using a
QIAmp Blood Kit (Qiagen, Hilden, Germany). To detect any
possible novel disease-causing mutations in MYOC, the three
coding exons and adjacent sequences of MYOC were screened
by polymerase chain reaction (PCR) followed by direct DNA
sequencing with a BigDye Terminator DNA sequencing kit
on a 3130XL analyzer (Applied Biosystems, Foster City, CA),
using the same set of primers that were used in our previous
study [17].
As for the other three genes, only polymorphisms that
might be informative in POAG genetics were selected for this
study. If any significant association was detected, further fine
mapping or re-sequencing of that gene will be performed.
Accordingly,  five  SNPs  in  OPTN  (c.603T>A  [M98K],  c.
1944G>A  [R545Q],  IVS5+38T>G,  IVS8–53T>C,  and
IVS15+10G>A) were selected, as they had been found to have
statistical association with POAG or have interaction with
other variants of the disease. They were genotyped by direct
sequencing according to the protocol of our previous studies
[3,16].  In  WDR36,  IVS5+30C>T  had  been  found  to  be
significantly associated with POAG in Hong Kong Chinese
(unpublished data), and therefore was investigated by direct
DNA sequencing, using the same pair of primers (primer for
the forward strand: 5′-TAG ATT AGT ATC TAA GTC TGT
GG-3′ and primer for the reverse strand: 5′-TGT TAT TTA
TAG  ACA  ACC  CTC  CA-3′).  In  APOE,  the  promoter
polymorphisms (−491A>T, −427T>C, and −219T>G) and the
ε2/ε3/ε4 polymorphisms in exon 4 (c.526C>T for ε2 and c.
388T>C for ε4) were investigated by the TaqMan genotyping
assays in an ABI Prism 7000 Sequence Detection System
(Applied  Biosystems)  according  to  the  manufacturer’s
instructions. The accuracy of genotyping with TaqMan was
evaluated  by  direct  sequencing  in  about  one  quarter  of
randomly selected samples according to the protocol of our
previous  study  [11].  Complete  matching  of  results  was
obtained.
Statistical  analysis:  Hardy–Weinberg  equilibrium  (HWE)
was tested for each polymorphism by the χ2 test. Allele or
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compared by the χ2 test or Fisher’s exact test. Significant
levels  for  multiple  comparisons  were  corrected  by  the
Bonferroni method. SPSS version15.0 software (SPSS Inc.,
Chicago, IL) was used.
Pairwise  linkage  disequilibrium  (LD)  estimation  and
expectation-maximization (EM)-based haplotype association
analysis were performed for the variants in MYOC, OPTN, and
APOE, respectively, using Haploview 4.0 [25].
LR analysis was used for gene-gene interactions only if
the variants were detected to have significant main effects.
The  disease  status  was  set  as  the  dependent  variable
(POAG=1,  control=0)  and  gene  polymorphisms  as  the
independent variables (homozygote=2, heterozygote=1, wild
type=0). The LR model was built with parameters for the
independent effects of both variants. If significant interaction
was detected, stratified analysis will be used to verify the
gene-gene interactions. The study subjects will be stratified
according to the genotype of one gene followed by the analysis
of another gene in a different stratum defined by the genotype
of the former gene. Homogeneity of the odds ratios (ORs) in
different strata will be tested by the Breslow-Day test.
High order gene-gene interaction models among all the
polymorphisms in the four candidate genes were detected and
characterized using the multifactor dimensionality reduction
(MDR) method as proposed by Ritchie et al. [23]. A detailed
explanation  on  the  MDR  method  has  been  described
elsewhere  [23,26,27].  Among  the  set  of  best  multifactor
models, the combination of genetic factors that maximizes the
testing  accuracy  and/or  the  highest  cross-validation
consistency (CVC) is selected and further evaluated using
permutation testing. p values associated with each prediction
error and cross-validation consistency were determined by the
Sign Test (a nonparametric test implemented in the MDR
software) and corrected by a permutation test. For the best
model, the interaction dendrogram, which was generated by
MDR,  was  used  to  confirm,  visualize,  and  interpret  the
interaction model. The MDR analysis was performed by using
the open-source MDR software package (version 1.0.0, freely
available online at Computation Genetics Laboratory).
RESULTS
Univariate analysis of individual polymorphisms in MYOC:
The allele and genotype frequencies of the MYOC variants
were summarized in Table 1. In total, 22 polymorphisms had
been  identified.  All  of  them  followed  HWE.  Association
analysis  showed  that  none  of  these  polymorphisms  was
statistically  associated  with  POAG  (p>0.0023,  Bonferroni
corrected  significance  level).  Four  variants  (Gln161Arg,
Gly183Ser, IVS1+16G>T, and Asn428Ser) were novel. They
were detected in controls only. In contrast, variants Gly12Arg,
Val53Ala, and Thr353Ile were found only in POAG cases
with Gly12Arg in three POAG patients and the other two each
in one patient. All were heterozygous. According to Alward’s
criteria  [28],  they  were  likely  disease-causing  mutations
(DCMs).
Distribution of single nucleotide polymorphisms in OPTN and
WDR36:  Genotypic  frequencies  of  OPTN  (Met98Lys,
Arg545Gln,  IVS5+38T>G,  IVS8–53T>C,  and
IVS15+10G>A) and WDR36 (IVS5+30C>T) followed HWE
in cases and controls. No significant difference was detected
between POAG cases and controls in the genotypic or allelic
frequencies (Bonferroni corrected significance level, p>0.01;
Table 2).
Univariate analysis of individual polymorphisms in APOE:
Genotypes of all the APOE polymorphisms, i.e., −491A>T,
−427T>C,  −219T>G,  and  the  ε2/ε3/ε4  polymorphism,
followed the HWE in both study groups. Their genotypic or
allelic distributions were not statistically different between
POAG patients and controls (p>0.0125, Bonferroni corrected
significance level, Table 3).
Haplotype association analysis for the variants in MYOC,
OPTN, and APOE: For MYOC, LD analysis revealed one LD
block, spanning from the promoter (−83G>A) to exon 1 (c.
227G>A). Within this block, polymorphisms −83G>A and c.
227G>A were the only two variants that had a minor allele
frequency (MAF) greater than 1%. They were in strong LD
(D’=0.974). The haplotype G-G, defined by the major alleles
of these two SNPs, presented in 95.5% of cases and 92.2% of
controls. It was not statistically associated with POAG. The
minor  haplotype  A-A  was  not  associated  with  glaucoma.
IVS2+35A>G was the only other MYOC polymorphism that
had  a  MAF  greater  than  1%.  When  it  was  included  in
haplotype  analysis,  none  of  the  haplotypes,  which  were
defined by the three SNPs, showed any significant association
with POAG (data not shown).
For OPTN, only five common variants were genotyped,
and no LD block was detected. We had tried every possible
combination  of  these  five  SNPs  to  evaluate  haplotype
association but found no haplotype significantly associated
with glaucoma (data not shown).
For APOE, only the three promoter SNPs and the ε2/ε3/
ε4 polymorphism in exon 4 were genotyped, and no LD block
was detected. Haplotype analysis showed that the common
haplotypes (frequency>5%), which are defined by the three
promoter SNPs (−491A>T, −427T>C, and −219T>G), were
not  associated  with  POAG.  When  the  ε2/ε3/ε4
polymorphisms (c.526C>T and c.388T>C) were included in
haplotype analysis, no common haplotype was found to be
significantly associated with glaucoma.
Gene–gene interaction analysis: Since we found no variant
having strong significant association with POAG, we did not
use logistic regression to build the interaction model. By using
MDR analysis, six models were formed (Table 4), a best
model  that  included  six  SNPs  from  all  four  genes  was
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IVS5+38T>G, and IVS8–53T>C in OPTN; IVS5+30C>T in
WDR36; and −491A>T in APOE. The combination of these
possibly  interactive  polymorphisms  in  the  model  gave  a
maximum CVC of 10/10 and a maximum testing accuracy of
0.5514. The p value associated with the prediction error and
CVC was 0.0107 (p<0.001 after corrected by permutation
test). Figure 1 illustrates the interaction dendrogram for this
model. The hierarchical cluster analysis placed IVS5+30C>T
(WDR36), IVS8–53T>C (OPTN), and Met98Lys (OPTN) on
the same branch, and their closer position in the diagram
clearly showed that the three SNPs may have a synergistic
interaction effect on modulating risk of POAG. IVS5+38T>G
(OPTN) and IVS2+35A>G (MYOC) were on another branch,
revealing an interaction between them. −491A>T (APOE)
was located on a different remote branch, suggesting that this
SNP may have less of a relationship with other SNPs.
DISCUSSION
For  the  first  time,  we  have  investigated  the  association
between multiple genes and POAG in a northern Chinese
population. In MYOC, we have detected four novel variants,
Gln161Arg, Gly183Ser, IVS1+16G>T, and Asn428Ser, each
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TABLE 1. MYOC POLYMORPHISMS IDENTIFIED IN THIS STUDY.
 
 
Location
 
Sequence
  change
 
 Codon
Change
Allele frequency (%)                                   Genotype frequency
POAG                        Control                       POAG                       Control
(n=352)        (n=400)        (n=176)              (n=200)
Promoter −126 T>C - 0 (0) 1 (0.25) 0/0/176 0/1/199
Promoter −83 G>A - 16 (4.5) 30 (7.5) 2/12/162 3/24/173
Exon 1 c. 34 G>C G12R* 3(0.85) 0 (0) 0/3/173 0/0/200
Exon 1 c. 57 G>T Q19H 0 (0) 1 (0.25) 0/0/176 0/1//199
Exon 1 c. 136 C>T R46X 2 (0.57) 3 (0.75) 0/2/174 0/3/197
Exon 1 c. 158 T>C V53A* 1 (0.28) 0 (0) 0/1/175 0/0/200
Exon 1 c. 227 G>A R76K 13 (3.69) 28 (7) 0/13/163 1/26/173
Exon 1 c. 369 C>T T123T 2 (0.57) 1 (0.25) 0/2/174 0/1/199
Exon 1 c. 482 A>G Q161R 0 (0) 1 (0.25) 0/0/176 0/1/199
Exon 1 c. 547 G>A G183S 0 (0) 1 (0.25) 0/0/176 0/1/199
Intron 1 IVS1+16 G>T - 0 (0) 1 (0.25) 0/0/176 0/1/199
Exon 2 c. 611 C>T T204M 0 (0) 2 (0.5) 0/0/176 0/2/198
Exon 2 c. 624 C>G D208E 1 (0.28) 3 (0.75) 0/1/175 0/3/197
Intron 2 IVS 2+35 A>G - 69 (19.6) 84 (21) 9/51/116 7/70/123
Intron 2 IVS 2+172 C>A - 4 (1.14) 1 (0.25) 0/4/172 0/1/199
Exon 3 c. 864 C>T I288I 1 (0.28) 1 (0.25) 0/1/175 0/1/199
Exon 3 c. 927 G>A Q309Q 0 (0) 1 (0.25) 0/0/176 0/1/199
Exon 3 c. 1041 T>C Y347Y 0 (0) 1 (0.25) 0/0/176 0/1/199
Exon 3 c. 1058 C>T T353I* 1 (0.28) 0 (0) 0/1/175 0/0/200
Exon 3 c. 1283 A>G N428S 0 (0) 1 (0.25) 0/0/176 0/1/199
Exon 3 c. 1464 C>T A488A 0 (0) 2 (0.5) 0/0/176 0/2/198
3′UTR 1515+73 G>C - 3 (0.85) 1 (0.25) 0/3/173 0/1/199
MYOC  polymorphisms identified by direct DNA sequencing in this study were shown it the table. The asterisk indicates that
the change is a disease-causing mutation and was found in POAG patients. The ‘hyphen’ represents non-coding variation. The
numbers under “Genotype frequency” are the counts of homozygotes, heterozygotes, and wild type.
TABLE 2. OPTN AND WDR36 POLYMORPHISMS INVESTIGATED IN THE PRESENT STUDY.
 
 
Gene
 
Sequence
  change
 
Codon
change
Allele frequency (%)                            Genotype frequency
 POAG                    Control                     POAG                     Control
(n=352)                    (n=400)                    (n=176)                     (n=200)
OPTN c.603 T>A M98K 39 (11.08) 48 (12) 3/33/140 3/42/155
OPTN c.1944 G>A R545Q 12 (3) 13 (3.25) 0/12/164 1/11/188
OPTN IVS5+38 T>G - 118 (33.5) 121 (30.25) 17/84/75 14/93/93
OPTN IVS8 −53 T>C - 27 (7.67) 24 (6) 1/25/150 1/22/177
OPTN IVS15+10G>A - 8 (2.27) 7 (1.75) 0/8/168 0/7/193
WDR36 IVS 5+30 C>T - 134 (38.1) 170 (42.5) 22/90/64 33/104/63
Allelic and genotypic frequencies of the five candidate SNPs in the present study were shown in the table. As only one WDR36
SNP  was selected, this SNP was also presented in this table. The “-” represents non-coding polymorphism. The numbers under
“Genotype frequency” are the counts of homozygotes, heterozygotes, and wildtype.in one control subject, but these variants were not found in
POAG patients (Table 1). From published reports, MYOC
mutations have been attributed to about 1%-4% of POAG
cases, and this rate can be as high as 36% in JOAG families
[29].  In  the  Chinese  population  of  Hong  Kong,  which  is
southern Chinese, the prevalence of MYOC mutations is about
1.1%–1.8% in POAG cases [2]. In this present study, the non-
synonymous  polymorphisms,  Gly12Arg,  Val53Ala,  and
Thr353Ile, were found only in POAG cases but not in controls.
According to Alward’s criteria [28], they were likely DCMs
for POAG. However, a previous study on Hong Kong Chinese
POAG  patients  showed  that  the  Gly12Arg  and  Thr353Ile
variants were not disease-causing; each of them was detected
in four control subjects (0.7%) [11]. Therefore, the remaining
Val53Ala variant might be the only DCM for POAG in the
northern Chinese group, accounting for only 0.6% of POAG
cases. Such a mutation rate is lower than that reported in
Caucasians and southern Chinese [2,29]. However, since the
Gly12Arg variant was detected in 3 of the 176 POAG patients
but none of the 200 healthy controls, we could not rule out its
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TABLE 3. APOE POLYMORPHISMS INVESTIGATED IN THE PRESENT STUDY.
   
Polymorphism
Allele frequency (%)                                                              Genotype frequency (%)
 
Allele
POAG                    Controls
(n=176)                     (n=400)
 
Genotype
POAG                     Controls
(n=176)                     (n=200)
−491 A>T T 8 (2.3) 13 (3.25) TT 0 (0) 0 (0)
  A 344 (97.7) 387 (96.75) TA 8 (4.5) 13 (6.5)
        AA 168 (95.5) 187 (93.5)
−427 T>C C 25 (7.1) 36 (9.0) CC 1 (0.6) 1 0.5 (0)
  T 327 (92.9) 364 (91.0) CT 23 (13.1) 34 (17.0)
        TT 152 (86.3) 165 (82.5)
−219 T>G G 93 (26.4) 117 (29.25) GG 10 (5.7) 15 (7.5)
  T 259 (73.6) 283 (70.75) GT 73 (41.5) 87 (43.5)
        TT 73 (52.8) 98 (49.0)
ε2/ε3/ε4 ε4 38 (10.8) 36 (9.0) ε4/ε4 3 (1.7) 2 (1.0)
  ε2 34 (9.7) 35 (8.75) ε2/ε4 5 (2.8) 4 (2.0)
  ε3 280 (79.5) 329 (82.25) ε3/ε4 29 (16.5) 28 (14.0)
        ε2/ε3 25 (14.2) 29 (14.5)
        ε2/ε2 2 (1.1) 1 (0.5)
        ε3/ε3 112 (63.6) 136 (68.0)
Allelic and genotypic frequencies of the four APOE  polymorphisms in case and control subjects were shown in the table. None
of them was significantly associated with POAG.
TABLE 4. MULTI-LOCUS INTERACTIONS BY THE MULTIFACTOR DIMENSIONALITY REDUCTION APPROACH.
Best candidate model* Testing accuracy (%) p value (sign test) CVC
−219T>G 43.61 0.999 5/10
IVS8–53T>C and IVS5+30C>T 52.5 0.377 7/10
IVS2+35A>G, IVS5+30C>T, and
−219T>G
43.59 1.0 4/10
IVS2+35A>G, IVS5+30C>T,
−219T>G, and 290C>T
47.53 0.945 9/10
A488A, IVS5+38, IVS5+30C>T,
−427T>C, and −219T>G
49.16 0.623 10/10
IVS2+35A>G, M98K,
IVS5+38T>G, IVS8–53T>C,
IVS5+30C>T, and −491A>T
55.14 0.0107 10/10
Interaction models with one to six factors generated by the MDR program were shown in the table. The six-factor model with
highest  CVC (10/10) and maximum testing accuracy (55.14%) was selected as the best model in this study. The asterisk indicates
that as the sample numbers in cases and controls are dissimilar in this study, the T value, which is the threshold ratio used to
distinguish high-risk genotype combinations from low risk genotype combinations, was set to 0.88 (number of cases/number
of controls, i.e., 176/200) while running the MDR program. CVC: cross-validation consistency.possibility of being a POAG-related variant in ethnic northern
Chinese. A larger sample size is required to confirm its role
on POAG. In addition, we found Gln19His in one control
subject, which was previously suggested to be a DCM [11].
This subject was a 69-year-old female with normal fundus.
She did not have a family history of glaucoma. Therefore, the
Gln19His variant is unlikely a disease-causing mutation for
POAG in northern Chinese. Apart from the rare variants, the
three common polymorphisms (MAF>1%), −83G>A, R76K,
and  IVS2+35A>G,  were  not  statistically  associated  with
POAG, consistent with findings in southern Chinese in Hong
Kong [11]. The allelic frequencies of these SNPs were also
found to be similar between the northern Chinese of this study
and the southern Chinese of Hong Kong (Table 5).
OPTN mutations had been reported to account for 1%–
1.6% of sporadic Chinese POAG patients [11,16]. However,
later  studies  reported  no  glaucoma  causing  mutations  in
OPTN  among  Caucasian  and  Japanese  POAG  patients
[30-32]. In this study, the five SNPs that were selected to be
genotyped had been reported to be either associated with
POAG individually or act interactively with other genes on
the disease [11,16]. After univariate analysis, none of them
showed significant association with glaucoma. However, we
found  that  the  allelic  distribution  of  the  selected  OPTN
variants among this present study population was different
from  the  southern  Chinese  population  [11].  The  allelic
frequencies  of  the  genotyped  OPTN  variants  in  the  two
populations  are  shown  in  Table  5.  The  exonic  SNP,
Met98Lys, presented a bit lower in the northern Chinese than
that  in  the  southern  Chinese,  but  the  difference  was  not
statistically  different  (χ2=2.6,  p>0.1  when  comparing  the
allelic frequencies of this variant in the control group in the
two studies, 12% versus 15.7% [11]). Another exonic variant,
Arg545Gln, and the intronic variant, IVS15+10G>A, also
showed  comparable  allelic  distributions  among  the  two
Chinese  populations.  However,  IVS5+38T>G,  which  was
significantly associated with POAG in the southern Chinese,
was found to be distributed drastically differently between the
two  populations.  It  occurred  in  12.4%  POAG  and  5.2%
controls in the southern Chinese. In contrast, in the northern
Chinese, this SNP was detected in 33.5% of cases and 30.25%
of  controls,  significantly  higher  than  that  in  the  southern
Chinese after adjustment for multiple comparison (in cases,
χ2=60.59, p=7.0×10−15; in controls, χ2=111.8, p=4.0×10−26).
Another intronic SNP, IVS8–53T>C, was also found to have
higher allelic frequencies in the northern Chinese, although
the p values became borderline after Bonferroni correction
(Table 5). Such difference in allelic distributions was also
found for APOE −427T>C, which presented at significantly
higher frequencies in the northern Chinese than the southern
Chinese  (Table  5).  Such  discrepancies  can  probably  be
explained by the presence of ancestry-related differences in
allele frequencies between the northern and southern Chinese.
However, only five SNPs in each of the two genes were
investigated  in  the  present  study.  Our  data  might  have
revealed only part of a discrepancy in the distribution pattern
of  OPTN  and  APOE  polymorphisms.  A  more  thorough
investigation of the sequences of these genes is warranted to
enable a more comprehensive comparison.
Recent  studies  suggested  that  WDR36  defects  may
contribute to the glaucomatous disease process as a glaucoma
modifier gene [33,34]. In a group of southern Chinese POAG
patients, only one SNP in WDR36, IVS5+30C>T, showed
significant  association  with  POAG,  and  it  is  a  common
polymorphism (unpublished data). However, this SNP did not
showed significant association with glaucoma in this study on
the northern Chinese.
Findings of this present study suggest that the roles of
MYOC, OPTN, WDR36, and APOE on the genetic architecture
of POAG are different among northern and southern Chinese.
To date, although variations in a variety of genes had shown
statistical associations with glaucoma, these associations were
often not replicable in other populations. Some of these SNPs
may be of functional significance, and their frequencies may
vary  significantly  between  different  ethnic  groups.  For
example, three DCMs at MYOC (Gly252Arg, Gly367Arg, and
Pro370Leu) were found in Asians and Caucasians, and three
(Thr293Lys,  Thr377Met,  and  Glu352Lys)  were  found  in
Africans and Caucasians. No single mutation was shared by
all three ethnic populations, suggesting most DCMs exist in a
specific ethnicity [29]. It may also suggest that a single gene
locus may not cause glaucoma but act interactively with other
gene variants [20]. Evidence for this hypothesis has been
reported.  Ishikawa  et  al.  [35]  found  the  APOE  promoter
polymorphism, −491A>T, interacted with MYOC −1000C>G
(MYOC.mt1)  to  increase  IOP  in  POAG  patients,  but  the
individual effect of MYOC.mt1 is unclear. Further, Funayama
et al. [12] found that common polymorphisms in OPTN and
olfactomedin 2 (OLFM2) may interactively contribute to the
development of OAG in Japanese patients. In the Chinese
population of Hong Kong, Fan et al. [11] detected three pairs
of  statistical  interactions  for  normal  tension  glaucoma
(between MYOC −83G>A and the APOE ε2/ε3/ε4, MYOC
IVS2+35A>G  and  APOE  −219T>G,  as  well  as  OPTN
Arg545Gln and APOE ε2/ε3/ε4)) and two pairs of interactions
for  POAG  (between  MYOC  Thr353Ile  and  OPTN
IVS15+10G>A and between OPTN IVS5+38T>G and APOE
−491A>T). In this present study, a best interaction model
involving six variants in MYOC,OPTN,WDR36, and APOE
had  been  identified  for  POAG  in  a  northern  Chinese
population by using MDR. This finding suggested that these
genes might act in concert to modulate the risk of POAG,
although MYOC attributed a more dominant effect. According
to  the  interaction  dendrogram,  the  variants,  WDR36
IVS5+30C>T and OPTN IVS8–53T>C, are expected to have
a strong synergistic interaction. OPTN Met98Lys has lesser
synergistic interaction with both. Similarly, variants OPTN
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.IVS5+38T>G  and  MYOC  IVS2+35A>G  also  have  strong
synergistic  interaction  themselves  but  having  lesser
interaction  with  the  three  variants  in  the  first  branch.
Moreover, APOE −491A>T may have the least degree of
interaction with other variants. This dendrogram provided
preliminary information about the interactive relationships
among the variants in the model. However, one limitation of
the MDR method is that it is difficult to evaluate the effects
of  each  individual  polymorphism  in  the  models  and  to
authenticate the combination of the risk alleles [36]. These
issues still need to be addressed. Another limitation of this
study  is  the  lack  of  replication.  As  the  interaction  model
detected in this study had not been identified in the southern
Chinese or other populations, it should be evaluated in other
Chinese populations.
In conclusion, we have for the first time investigated the
roles of polymorphisms in MYOC, OPTN, WDR36, and APOE
in POAG in a group of northern Chinese. The distributions of
some  variants  were  drastically  different  from  that  in  the
general southern Chinese population. The possibly disease-
causing  mutations  in  MYOC  accounted  for  only  a  small
proportion of northern Chinese POAG patients. The common
polymorphisms in the candidate genes were not significantly
associated  with  glaucoma,  although  a  larger  sample  of
northern  Chinese  should  be  required  to  unravel  their
contributions to POAG if their effects are mild. However,
some of the common polymorphisms in these genes might
interactively  contribute  to  POAG,  supporting  a  polygenic
etiology of this common and complex disease.
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